Monday, 24 Feb 2020

You are here

Physical Activity Lowers Fracture Risk in Post-Menopausal Women

An analysis from the Women’s Health Initiative study shows that postmenopausal women who participate in vigorous physical activity have a statistically lower risk of total and site-specific fractures

The study included 77,206 postmenopausal women who were seen between 1993-2019, for a mean of 14 years, and stratified according to the level (total, mild, moderate to vigorous, and walking) of physical activity.  The primary outcomes were total fracture risk, including fractures of the hip, spine, wrist and knee. 

One-third (33.1%) of subjects experienced a first incident fracture. Total physical activity was inversely associated with the adjusted risk of hip fracture (>17.7 MET h/wk vs none: HR, 0.82; 95% CI, 0.72-0.95; P for trend < .001).

Lower hip fracture rates were also observed for actively engaged in walking (HR 0.88), mild activity (HR 0.82), moderate to vigorous activity (HR 0.88), and yard work (HR 0.90). Mild activity lowered the risksof vertebral fracture (HR 0.87) and total fractures (HR 0.91).

Increased fracture risk was seen between knee fracture and total physical activity (HR, 1.26) and moderate to vigorous activity was positively associated with wrist or forearm fracture (HR 1.09).  Sedentary time was minimally but positively associated with total fracture risk (HR, 1.04).

In premenopausal, ambulatory women, total and hip fracture risks were attenuated by physical activity - including mild activity and walking. Its unclear if there is an association between sedentary time and total fracture risk.

The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

JAK Inhibitors Stimulate Osteoblasts

Science Translational Medicine has a report on how the use of Janus kinase (JAK) inhibitors may boost osteoblasts to battle bone erosions in conditions like rheumatoid arthritis (RA).

JAK inhibitors have been shown in clinical trials to retard the development of bone erosions while controlling RA inflammation and other clinical features.

Hormone Therapy for Postmenopausal Women

The NEJM weighs in on the problem of post-menopausal osteoporosis (OP) and tackles the use of hormonal therapy. The decline in estrogen after menopause may increase risks for osteoporosis, cardiovascular disease, and cognitive decline. The use of hormone replacement therapy (HRT) to obviate these issues may be primarily driven by hot flashes in postmenopausal women.1 Who may benefit from hormone therapy among postmenopausal women?

Knee Replacements Last 25 Years

UK registry reports that greater than 80% of total knee replacements can last for 25 years.

The outcomes regarding the duration and durability of knee arthroplasties is sketchy, with many orthopedists projecting a 15 to 20 year survivial. Hence the need for an appraisal of the data.

Should We Screen Younger Postmenopausal Women for Osteoporosis?

Do postmenopausal women, under age 65 years, need a baseline BMD testing? A JAMA Insights review suggests that the absolute risk of fracture is low in this group and that USPSTF guidelines should be considered - that we should be screening women younger than 65 years who are at increased risk of osteoporosis and we should be using a formal risk assessment tool to identify candidates for bone density testing.

Genicular Artery Embolization to Treat Osteoarthritis Knee Pain

A study from the Journal of Vascular and Interventional Radiology has shown that  knee pain secondary to osteoarthritis (OA) may be effectively treated by selective vascular interruption (embolization) showing efficacy and safety in a small pilot trial.